129 related articles for article (PubMed ID: 17459280)
1. P27 and MIB-1 expression is related to malignancy recurrence in laryngeal carcinoma treated with partial laryngectomy: preliminary results.
Calgaro N; Marioni G; Blandamura S; Giacomelli L; Stramare R; Bertolin A; Staffieri A; de Filippis C
J Otolaryngol; 2007 Apr; 36(2):98-105. PubMed ID: 17459280
[TBL] [Abstract][Full Text] [Related]
2. Supracricoid partial laryngectomy for primary and recurrent laryngeal cancer.
Sperry SM; Rassekh CH; Laccourreye O; Weinstein GS
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1226-35. PubMed ID: 24092390
[TBL] [Abstract][Full Text] [Related]
3. High prognostic impact of growth fraction parameters in advanced stage laryngeal squamous cell carcinoma.
Valente G; Giusti U; Kerim S; Gabriele P; Motta M; Ragona R; Navone R; Palestro G
Oncol Rep; 1999; 6(2):289-93. PubMed ID: 10022991
[TBL] [Abstract][Full Text] [Related]
4. Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx.
Marioni G; Blandamura S; Giacomelli L; Calgaro N; Segato P; Leo G; Fischetto D; Staffieri A; de Filippis C
Histopathology; 2005 May; 46(5):576-82. PubMed ID: 15842640
[TBL] [Abstract][Full Text] [Related]
5. Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3.
Dufour X; Hans S; De Mones E; Brasnu D; Ménard M; Laccourreye O
Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1092-9. PubMed ID: 15381597
[TBL] [Abstract][Full Text] [Related]
6. Pathological validation of supracricoid partial laryngectomy in laryngeal cancer.
Sun DI; Cho KJ; Cho JH; Joo YH; Jung CK; Kim MS
Clin Otolaryngol; 2009 Apr; 34(2):132-9. PubMed ID: 19413611
[TBL] [Abstract][Full Text] [Related]
7. Expression of p27 and PTEN and clinical characteristics in early laryngeal squamous cell carcinoma and their correlation with recurrence.
Yang JQ; Liang Z; Wu M; Sun YM; Liu HX
Int J Clin Exp Pathol; 2015; 8(5):5715-20. PubMed ID: 26191286
[TBL] [Abstract][Full Text] [Related]
8. Treatment for T3 to T4a laryngeal cancer by open partial horizontal laryngectomies: Prognostic impact of different pathologic tumor subcategories.
Succo G; Crosetti E; Bertolin A; Piazza C; Molteni G; Cirillo S; Petracchini M; Tascone M; Sprio AE; Berta GN; Peretti G; Presutti L; Rizzotto G
Head Neck; 2018 Sep; 40(9):1897-1908. PubMed ID: 29756363
[TBL] [Abstract][Full Text] [Related]
9. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
[TBL] [Abstract][Full Text] [Related]
10. Benefits and drawbacks of open partial horizontal laryngectomies, Part A: Early- to intermediate-stage glottic carcinoma.
Succo G; Crosetti E; Bertolin A; Lucioni M; Caracciolo A; Panetta V; Sprio AE; Berta GN; Rizzotto G
Head Neck; 2016 Apr; 38 Suppl 1():E333-40. PubMed ID: 25581514
[TBL] [Abstract][Full Text] [Related]
11. Association of Positive Initial Margins With Survival Among Patients With Squamous Cell Carcinoma Treated With Total Laryngectomy.
Tassone P; Savard C; Topf MC; Keane W; Luginbuhl A; Curry J; Cognetti D
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1030-1036. PubMed ID: 30054637
[TBL] [Abstract][Full Text] [Related]
12. Supracricoid laryngectomy with cricohyoidopexy for recurrence of early-stage glottic carcinoma after irradiation. Long-term oncological and functional results.
Marchese-Ragona R; Marioni G; Chiarello G; Staffieri A; Pastore A
Acta Otolaryngol; 2005 Jan; 125(1):91-5. PubMed ID: 15799582
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive analysis of selected diagnostic methods with respect to their usefulness in evaluating the biology of neoplastic cells in patients with laryngeal cancer.
Golusinski W; Olofsson J; Szmeja Z; Biczysko W; Krygier-Stojałowska A; Kulczyński B
Eur Arch Otorhinolaryngol; 1999; 256(6):306-11. PubMed ID: 10456281
[TBL] [Abstract][Full Text] [Related]
14. One hundred supracricoid laryngectomies with cricohyoidoepiglottopexy: do we achieve better local control?
Nakayama M; Miyamoto S; Seino Y; Okamoto T; Kano K; Hasebe M; Okamoto M
Jpn J Clin Oncol; 2015 Aug; 45(8):732-7. PubMed ID: 25981622
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
16. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy and cricohyoidopexy for glottic and supraglottic carcinomas.
Bron L; Brossard E; Monnier P; Pasche P
Laryngoscope; 2000 Apr; 110(4):627-34. PubMed ID: 10764009
[TBL] [Abstract][Full Text] [Related]
17. [Long term results of partial laryngectomies in patients suffering from laryngeal cancer].
Kardasz-Ziomek M; Scierski W; Namysłowski G; Majewski W
Otolaryngol Pol; 2012; 66(1):46-50. PubMed ID: 22381015
[TBL] [Abstract][Full Text] [Related]
18. Expression of PTEN protein in patients with laryngeal squamous cell carcinoma.
Guney K; Ozbilim G; Derin AT; Cetin S
Auris Nasus Larynx; 2007 Dec; 34(4):481-6. PubMed ID: 17475427
[TBL] [Abstract][Full Text] [Related]
19. Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer.
Farrag TY; Lin FR; Cummings CW; Koch WM; Flint PW; Califano JA; Broussard J; Bajaj G; Tufano RP
Laryngoscope; 2006 Oct; 116(10):1864-6. PubMed ID: 17003711
[TBL] [Abstract][Full Text] [Related]
20. Horizontal partial laryngectomy for supraglottic squamous cell carcinoma.
Bron LP; Soldati D; Monod ML; Mégevand C; Brossard E; Monnier P; Pasche P
Eur Arch Otorhinolaryngol; 2005 Apr; 262(4):302-6. PubMed ID: 15316823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
